for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-L.I.A. Pure Capital Ltd Reports 12.58% Stake In Therapix Biosciences As Of May 31 2020

June 2 (Reuters) - Therapix Biosciences Ltd:

* L.I.A. PURE CAPITAL LTD REPORTS 12.58% STAKE IN THERAPIX BIOSCIENCES AS OF MAY 31 2020 - SEC FILING

* L.I.A. PURE CAPITAL LTD SAYS ACQUIRED THERAPIX BIOSCIENCES ADSS BECAUSE THEY BELIEVE THAT THE ADSS ARE UNDERVALUED

* L.I.A. PURE CAPITAL LTD SAYS INTENDS TO SEEK POSITIONS OF THERAPIX BIOSCIENCES’S BOARD AND MAY SEEK TO GAIN CONTROL INTEREST IN THERAPIX BIOSCIENCES Source text: (bit.ly/2XoZlwW) Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up